Beta Amyloid Oligomers with Higher Cytotoxicity have Higher Sidechain Dynamics

Area of Science:

• Biochemistry
• Biophysics
• Neuroscience

Background:

• The cytotoxicity of beta-amyloid (Aβ) oligomers is a key factor in Alzheimer's disease pathogenesis.
• The precise biophysical mechanisms driving Aβ oligomer cytotoxicity remain poorly understood.

Purpose of the Study:

• To investigate the relationship between Aβ₄₀ oligomer size, structure, dynamics, and cytotoxicity.
• To control and compare the properties of distinct Aβ₄₀ oligomer sizes.

Main Methods:

• Incubation of Aβ₄₀ peptides in reverse micelles to control oligomer size.
• Solid-state Nuclear Magnetic Resonance (NMR) spectroscopy to analyze structure and dynamics.
• Cytotoxicity assays to evaluate biological activity.

Main Results:

• Successfully controlled Aβ₄₀ oligomer sizes to 10-nm and 23-nm.
• Identified differences in residue conformation and chemical environment (K16-K28) between the two sizes.
• Demonstrated that 10-nm Aβ₄₀ oligomers exhibit higher cytotoxicity and increased sidechain dynamics at residue K16.
• Observed unusual structural rigidity at residue A21 in Aβ₄₀ oligomers.

Conclusions:

• Oligomer size is a critical determinant of Aβ₄₀ cytotoxicity.
• Cytotoxicity may be correlated with the motional dynamics of specific amino acid sidechains within Aβ₄₀ oligomers.
• This study provides novel insights into the biophysical basis of Aβ-mediated neurotoxicity.